United States Biodefense-Related Rapid Pathogen Identification and Treatments Markets Outlook Report: Data from 2019-2020, estimates for 2021 and CAGR projections to 2026
12. November 2021 05:13 ET
|
Research and Markets
Dublin, Nov. 12, 2021 (GLOBE NEWSWIRE) -- The "The U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments 2021-2026" report has been added to ResearchAndMarkets.com's...
L’activité exceptionnelle du DNV3681 contre des menaces bioterroristes présentée à l’ASM Microbe 2019
24. Juni 2019 12:00 ET
|
Deinove
L’activité exceptionnelle du DNV3681 contre des menaces bioterroristes présentée à l’ASM Microbe 2019 Le Major Steven Zumbrun (USAMRIID1, Département de la Défense des Etats-Unis) a présenté la...
DNV3681's exceptional activity against bioterrorist threats presented at ASM Microbe 2019
24. Juni 2019 12:00 ET
|
Deinove
DNV3681's exceptional activity against bioterrorist threats presented at ASM Microbe 2019 Major Steven Zumbrun (USAMRIID1, U.S. Department of Defense) presented data on the in vitro assessment of...
PositiveID Corporation Announces the Launch of its Multiplex BioThreat Assay, the First Commercially Available Product of its Kind
21. Juni 2011 08:30 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., June 21, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (Nasdaq:PSID), a developer of medical technologies for diabetes management, clinical...